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ABSTRACT
All nuclear RNA polymerases are phosphoprotein
complexes. Yeast RNA polymerase I (Pol I) contains
approximately 15 phosphate groups, distributed to
5 of the 14 subunits. Information about the function
of the single phosphosites and their position in the
primary, secondary and tertiary structure is lacking.
We used a rapid and efficient way to purify
yeast RNA Pol I to determine 13 phosphoserines
and –threonines. Seven of these phosphoresidues
could be located in the 3D-homology model for Pol I,
five of them are more at the surface. The single
phosphorylated residues were systematically
mutated and the resulting strains and Pol I prepara-
tions were analyzed in cellular growth, Pol I
composition, stability and genetic interaction with
non-essential components of the transcription
machinery. Surprisingly, all Pol I phosphorylations
analyzed were found to be non-essential post-
translational modifications. However, one mutation
(subunit A190 S685D) led to higher growth rates in
the presence of 6AU or under environmental stress
conditions, and was synthetically lethal with a
deletion of the Pol I subunit A12.2, suggesting a
role in RNA cleavage/elongation or termination. Our
results suggest that individual major or constitu-
tively phosphorylated residues contribute to non-
essential Pol I-functions.
INTRODUCTION
Phosphoprotein complexes are involved in many biologi-
cal processes. Although reversible phosphorylation at
distinct sites and their consequences for complex function
was extensively studied in many cases, a systematic
functional and structural analysis of the predominant or
stoichiometric phosphorylated residues within multipro-
tein complexes is rare. All three nuclear RNA polymerases
are phosphoprotein complexes (1–3). Phosphorylation
and function of the C-terminal domain of the largest
Pol II subunit were analyzed in detail (4), but not much is
known about the positions and roles of phosphorylation
sites in other Pol I, Pol II and Pol III subunits. Yeast
RNA Pol I consists of 14 subunits, 5 of which are phos-
phorylated in vivo (1–3): A190, the largest Pol I subunit,
comprising part of the active site (5,6); A43, the inter-
action partner of the Pol I-speciﬁc transcription factor
Rrn3p (7); the non-essential subunit A34.5, which inter-
acts with the non-essential subunit A49 and was suggested
to be involved in RNA elongation (8,9); ABC23
(= Rpb6), a subunit common to all three RNA poly-
merases, which is involved in enzyme assembly (10,11) and
forms the main interaction interphase for the A43/A14
heterodimer (12,13); and AC19, one of the a-like subunits,
shared by Pol I and Pol III, which is crucial for the
assembly of the polymerase core (6,14,15). Although
mammalian rRNA synthesis is mainly regulated by phos-
phorylation of Pol I-speciﬁc transcription factors (16,17),
our previous analyses suggested that in yeast also the
phosphorylation state of Pol I itself inﬂuences transcrip-
tion of rRNA genes (18,19). Since its activity to synthesize
rRNA is required for growth, Pol I represents an appro-
priate model both to investigate systematically in vivo the
meaning of the major phosphorylated residues of a large
phosphoprotein complex and to learn about their role in
Pol I-activity. Furthermore, rRNA synthesis responds
extremely sensitive to any slight changes in environmental
conditions through signal transduction pathways. Thus,
it should be possible to get insights whether and how the
major phosphosites function in transcription regulation.
Recent developments in mass spectrometry allowed to
determine large numbers of phosphopeptides within
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phosphopeptides of the nuclear RNA polymerases could
be determined in these proteome-wide analyses (22–24).
To obtain a more precise picture, we employed phospho-
peptide mapping from puriﬁed polymerase fractions. We
developed a new strategy to purify Pol I to homogeneity
on a large scale. Using LC-MALDI-TOF/TOF mass
spectrometry in combination with a chemical derivatiza-
tion procedure (25,26), it was possible to determine the
major phosphorylated Pol I residues, i.e. 13 phosphoser-
ines and -threonines on the ﬁve subunits that are phos-
phorylated in vivo. Approximate or exact positions of the
phosphorylated residues were located in either the homo-
logy model for the Pol I core enzyme or in the crystal
structure of the Pol I subcomplex A14-A43 (9). After
systematically replacing the phosphorylated amino acids
by either alanine or aspartate to mimic a constitutively
unphosphorylated or phosphorylated state, respectively,
the resulting mutant strains were investigated in growth
ability, Pol I subunit stability and —stoichiometry as well
as in genetic interactions with non-essential components
of the Pol I-transcription machinery. Surprisingly, our
analyses demonstrate that most of the individual pre-
dominant or stoichiometrically phosphorylated residues
of Pol I have no direct inﬂuence in Pol I assembly or
essential steps of rRNA synthesis. Only one of the abun-
dant Pol I-phosphorylation sites was found to play a
detectable role in Pol I-activity. The same mutation was
also the only one detected to genetically interact with
another constituent of the Pol I machinery, the non-
essential subunit A12.2. Our analyses suggest that
reversible modiﬁcation of A190 S685 is involved in
RNA cleavage/elongation and/or termination.
MATERIALS AND METHODS
Pol I purification
A puriﬁcation scheme is shown in Figure 1A and
Supplementary Fig. S1A. Strain GPY2, carrying the
gene for an N-terminal His6/HA-tagged A43 on a plasmid
was cultivated to OD600=5–6at 308C in YPD media in a
200l fermenter (Infors ABEC). The cells were harvested
by continuous ﬂow centrifugation (Padberg) and lysed by
bead beating in ice-cold buﬀer A (400mM (NH4)2SO4,
60mM MgCl2, 150mM HEPES pH 7.8, 30% glycerol,
5mM DTT, 1mM PMSF, 1mM benzamidine, 200mM
pepstatin, 60mM leupeptin). All subsequent steps were
performed at 48C. Glass beads were separated by ﬁltration
prior to clearing the lysate by centrifugation (30min,
8000g, Sorvall SLA-1500). The ﬁnal whole cell extract
(WCE) was obtained after centrifugation at 100000g for
90min (Beckman SW28) by separating the clear middle
phase from the turbid lower phase. The WCE was
dialyzed against buﬀer B (50mM KAc, 20mM HEPES
pH 7.8, 1mM MgCl2, 10% glycerol, 1mM PMSF, 1mM
benzamidine) over night, using Spectra/Por 2 dialysis
tubing (MWCO 12–14kDa) (Spectrum Laboratories).
After centrifugation at 30000g for 1h (Beckman Ti45),
the pellet was resuspended in buﬀer C (1.5M KAc, 20mM
HEPES pH 7.8, 1mM MgCl2, 10% glycerol, 1mM
PMSF, 1mM benzamidine) and applied to 4ml Ni-NTA
Figure 1. RNA polymerase I puriﬁcation and identiﬁcation of phosphorylation sites. (A) Pol I puriﬁcation scheme. See Supplementary Figure S1 for
the extended scheme, including an additional cation exchange chromatography step. (B) Coomassie staining of puriﬁed Pol I [C] and phosphoprotein
staining of the same gel [P] using phosphostain ProQ Diamond (Invitrogen). Three proteins of an eIF3 subcomplex co-puriﬁed with Pol I, namely
Rpg1p (1
 ), Nip1p (2
 ) and Prt1p (3
 ). (C) Scheme of the strategy used for the identiﬁcation of phosphorylation sites from puriﬁed Pol I.
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performed in batch for 4h on a turning wheel, before
pouring the suspension into disposable Econo-Pac
TM
columns (Bio-Rad) for subsequent wash-steps with
buﬀer C and buﬀer D (300mM KAc, 20mM HEPES
pH 7.8, 1mM MgCl2, 10% glycerol) and elution with
buﬀer E (buﬀer D+100mM imidazole). The eluting
proteins were loaded onto a Mono Q anion exchange
column (Mono Q
TM 10/100 GL, GE Healthcare) and
fractionated by applying a salt gradient from 300mM to
2M KAc with buﬀers F (20mM HEPES pH 7.8, 1mM
MgCl2, 10% glycerol) and G (buﬀer F+2M KAc). The
pooled Pol I containing fractions (eluting at 1.1M KAc)
were either directly applied to the gelﬁltration chromato-
graphy step (Figure 1A and B) or, to obtain the highest
purity, subjected to cation exchange chromatography
(Supplementary Fig. S1). To enable binding to the
Mono S column (Mono S
TM 5/50 GL, GE Healthcare),
the Mono Q eluate was diluted to a salt concentration of
200mM KAc with buﬀer F, loaded onto the column and
fractionated by applying a gradient from 200mM to 2M
KAc using buﬀers F and G, with Pol I eluting at 490mM
KAc. Finally the combined Pol I peak fractions from
either the Mono Q or the additional Mono S chromato-
graphy were concentrated to a volume of 500ml using an
Amicon
TM Ultra–4 centrifugal ﬁlter unit (MWCO
100kDa, Millipore) and applied to gelﬁltration chroma-
tography on a Superose 6 column (Superose
TM 6 10/300
GL, GE Healthcare) with buﬀer H [60mM (NH4)2SO4,
5mM HEPES pH 7.8, 1mM MgCl2,1 0 mM ZnCl2,
5mM DTT].
Phosphoprotein staining
SDS–polyacrylamide gels were stained with Pro–Q
TM
Diamond Phosphoprotein stain (Invitrogen) according
to the manufacturer’s instructions and visualized on
a 315nm UV transilluminator. The same gel was then
stained with SimplyBlue
TM SafeStain (Invitrogen) for
total protein staining.
Identification ofphosphorylation sites
Following in-gel digestion,  37.5pmol of the tryptic
peptides of any phosphorylated Pol I subunit were used
for the chemical derivatization at a time. The sulfhydryl
groups of the cysteine residues were protected by
reduction with 10mM DTT at 378C and carboxymethyla-
tion with 35mM Iodoacetic acid at 248C for 1h each. The
b–elimination and Michael-addition reactions were per-
formed in a single step by incubation of the alkylated
peptides in the presence of 64.5mM Ba(OH)2 [taken from
a freshly prepared saturated Ba(OH)2 solution] with either
450mM ethanethiol or 400mM pentanethiol in 30%
acetonitrile at 508C for 90min. The reactions were stopped
by precipitation of BaCO3 after the addition of NH4HCO3
to the ﬁnal concentration of 100mM. Residual alka-
nethiols, NH4HCO3 and acetonitrile were removed by
lyophilization. The modiﬁed peptides were either analyzed
after desalting with ZipTip
TM C18 pipette tips (Millipore)
as described for protein identiﬁcation (Supplementary
Methods) or fractionated via C18 reversed phase liquid
chromatography. The latter was performed using a
Dionex UltiMate
TM nanoHPLC applying a gradient
from 15 to 60% acetonitrile/0.05% TFA at a ﬂow rate
of 300nl/min within 90min. Fractions were mixed with
CHCA matrix and collected directly on the MALDI-
target using a Dionex Probot
TM system. All samples were
analyzed on an Applied Biosystems 4700 Proteomics
Analyzer
TM MALDI-TOF/TOF mass spectrometer.
Identiﬁcation of the originally phosphorylated residues
is based on the unique mass shift of +44.0085Da (for
ethanethiol) or +86.0554Da (for pentanethiol) compared
to the expected mass of an unmodiﬁed serine or threonine.
A customized Pol I sequence database (including trypsin
and all co-purifying proteins) was used to allow more
variables in the search parameters and the results were
conﬁrmed by searching against the NCBInr protein
sequence database.
RESULTS AND DISCUSSION
Identificationand3D-localizationofmajorPolI-phosphosites
To generate homogenous Pol I on large scale we modiﬁed
a previously developed puriﬁcation protocol for active
Pol I initiation complexes. We took advantage of the fact
that soluble Pol I complexes in WCEs can be precipitated
by dialysis against buﬀers with low ionic strength (27,28).
This precipitation step reduces signiﬁcantly the volume of
the Pol I containing fraction and, thus, facilitates large-
scale puriﬁcation. Subsequent puriﬁcation of His-tagged
Pol I (N-terminal His-tag on subunit A43) on Ni-Agarose,
chromatography on MonoQ and MonoS, and gelﬁltration
on Superose 6 yielded an overall recovery of 5mg Pol I
from 200l yeast culture (Figure 1A and B and Supple-
mentary Fig. S1). The purity of this Pol I fraction
(Supplementary Fig. S1B) enabled structure determina-
tion at 12A ˚ by cryo electron microscopy (9). The quality
of the puriﬁed Pol I was also appropriate to determine
Pol I-speciﬁc phosphopeptides. Staining of puriﬁed Pol I
fractions using the phosphostain Pro-Q Diamond
(Invitrogen) revealed that all ﬁve in vivo phosphorylated
subunits (1–3,29) remained phosphorylated after puriﬁca-
tion (Figure 1B). The puriﬁed Pol I was tested to be active
in non-speciﬁc transcription assays (data not shown).
To identify phosphorylated peptides after tryptic diges-
tion of the single Pol I subunits, we used a chemical
derivatization procedure to replace the phosphogroups by
either ethanethiol (S-EtSH) or pentanethiol (S-PeSH)
(25,26). In combination with C18 reversed phase liquid
chromatography, this method overcomes some of the
problems associated with the analysis of phosphorylated
peptides in MALDI–MS, like the neutral loss of
H3PO4 and suppression eﬀects (30), while increasing the
ionization eﬃciency of the modiﬁed peptides (26,31).
The originally phosphorylated serines or threonines
could then be identiﬁed by their additional mass of
+44.0085Da (S-EtSH) or of +86.0554Da (S-PeSH)
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11 phosphopeptides (Table 1), including a total of 13
phosphoserines and –threonines; four on subunit A43,
three on each of the subunits A190 and A34.5, two on
subunit AC19, which is shared in Pol III, and one on
subunit ABC23 (= Rpb6), which is common to all three
RNA polymerases. Our results complement the identiﬁca-
tion of phosphoserines S1413/S1415/S1417 (22) and S1636
on subunit A190 (24) in proteome-wide large-scale
approaches. These recent analyses also conﬁrmed one
of the four herein described phosphoserines on subunit
A43 (S285), the triple cluster on A34.5 (S10/S12/S14) and
one of two phosphothreonines found in subunit AC19
(T33), using a completely diﬀerent methodology (23,24).
The positions of the phosphosites in the primary structure
with regard to the domain organization of the subunits
and in the context of published mutations that lead to
a growth phenotype are indicated in Figure 2. Overall, the
number of the so far identiﬁed phosphosites approxi-
mately matches the calculated 15 3 phosphate groups
per enzyme and the average number of in vivo phosphory-
lated residues (6 for A190, 4 for A43, 2 for A34.5, 1 or 2
for ABC23, 1 or 2 for AC19, respectively) (29), indicating
that most of the constitutively or strongly phosphorylated
sites could be determined. However, it is possible that
additional phosphosites exist, which have not been
detected yet, either due to methodological constraints or
due to limited cellular amounts of the respective Pol I
population, like the initiation active Pol I-Rrn3p complex.
Using the complete Pol II structure (32), a recently
established Pol I-cryo-EM structure and a new crystal
structure of the Pol I subcomplex A43-A14, a model of
a 12-subunit form of Pol I has been constructed (9). Based
on this model and the sequence conservation between
Pol I and Pol II subunits, the 3D-positions of seven
phosphorylated residues were allocated (Figure 3A
and B). Interestingly, all phosphosites except two (A190
S936/941 and ABC23 S102) are located more at the
surface of the enzyme indicating that they could be acces-
sible by modifying enzymes. The most striking position
is that of S936/941 in the funnel domain of A190
(Figure 3C). The side chain of S936 points towards the
pore/funnel through which the nucleotides are presumed
to enter (33) and into which the 30 end of the RNA chain is
apparently extruded during backtracking of the enzyme.
Many residues (including S936/941) in the funnel- and
pore 1-domains are highly conserved among species as
well as among nuclear RNA polymerases and are
apparently important for the mechanism of NTP-
binding, -selection and -incorporation [Figure 3C and
(34)]. For instance, yeast Rpb1 K752, which is identical to
K934 in A190, is crucial for NTP binding in the A-site
(34–36). Thus, it was surprising that neither replacement
of S936 nor of S941 by alanine, aspartate or even gluta-
mate resulted in a severe growth phenotype (see subse-
quently). Apparently, the nucleotides can still pass
through the funnel without constraint despite the obvious
steric and electrochemical hindrance of a negatively
charged side chain that occupies a signiﬁcant part of the
pore/funnel. To allow eﬃcient passage of NTPs, it is
possible that the funnel region is more ﬂexible than antici-
pated from its crystal structure. Furthermore, the move-
ment of the trigger loop during NTP incorporation (35) is
apparently not inﬂuenced by changing the negative charge
and the amino acid side chain at the positions S936/941.
A190 S685 is another phosphorylation site of the
pore/funnel region. In contrast to S936/941, this residue
is not located inside the pore but on the part of the
pore 1-domain which contributes to the backside of the
polymerase (Figure 3D). A190 S685 lies in the vicinity of
ABC14.5, the AC40/AC19 heterodimer and a conserved
loop of the hybrid binding-domain of A135.
Only one phosphorylation site in subunit A43 falls
within the ordered part of the new crystal structure,
whereas the others are located to its mobile C-terminal
region or within a disordered loop that are not revealed
Table 1. Identiﬁed Pol I phosphopeptides and –sites and corresponding amino acids in the Pol I homology model
Subunit Phosphopeptide 3D-localization
Position Sequence
a Phosphosite Amino acid in homology model
b
A190 352–366 ADSFFMDVLVVPPTR S354 Rpb1 W234
684–689 DSFFTR S685 Rpb1 T539
935–955 GSNVNVSQIMCLLGQQALEGR S936 or S941
c Rpb1 S754/A759
A43 207–212 FSFGNR S208 N/D
213–228 SLGHWVDSNGEPIDGK S220 A43 S220
242–264 VVSVDGTLISDADEEGNGYNSSR S262 or S263
c N/D
278–289 IVFDDEVSIENK S285 N/D
A34.5 7–31 DYVSDSDSDDEVISNEFSIPDGFKK S10/S12/S14 N/D
ABC23 98–119 ALQISMNAPVFVDLEGETDPLR S102 ABC23 S102
AC19 21–46 HIQEEEEQDVDMTGDEEQEEEPDREK T33 Rpb11 A3
49–77 LLTQATSEDGTSASFQIVEEDHTLGNALR T51 or T54 or S55
c Rpb11 I21/D24/T25
aPhosphoserines/-threonines are presented as bold, underlined characters.
bSome phosphosites could not be localized in the Pol I homology model due to weak homology of the respective protein regions to Pol II, missing
homologous subunits or deletions in the A43/14 crystal structure.
cThree phosphopeptides could be identiﬁed due to the speciﬁc mass shift after chemical derivatization and a partial MS/MS spectrum, but the
phosphorylation site could not be unambiguously assigned. The remaining possible serines and threonines are shown in bold, italic letters in the
peptide sequence.
796 Nucleic Acids Research, 2008, Vol. 36, No. 3Figure 2. Phosphorylation sites of Pol I. Positions of the identiﬁed Pol I phosphorylation sites in the primary structure of the ﬁve phosphorylated
subunits. Phosphorylation sites marked with an asterisk were conﬁrmed by proteome-wide, large-scale phosphorylation analyses (see text).
Sites identiﬁed exclusively by proteome-wide analyses are marked by a triangle. The domain organization of the subunits and the positions of amino
acid exchanges of known Pol I mutants are shown, as well as a part of the secondary structure of A43. References: [1] (22); [2] (24); [3] (9); [4] (53);
[5] (23); [6] (54); [7] (7); [8] (55); [9] (10); [10] (45); [11] (15).
Nucleic Acids Research,2008, Vol. 36,No. 3 797by crystallography (9). The phosphorylated S220 localizes
between the C2 and C3 b-sheets which form together with
the b-sheet C1 the outermost part of the A43-OB domain
(9). The exposed position of S220 on the OB domain,
the fact that A43 plays a crucial role in transcription
initiation (7) and the ﬁndings that mutants with truncated
b-sheets in this region are severely aﬀected in growth
ability (Figure 2), makes this region an appropriate
Figure 3. Three-dimensional localization of the identiﬁed Pol I phosphorylation sites. Localization of the phosphorylated amino acids in the Pol I
homology model (9). The polymerase core and the A43/A14 heterodimer are shown in gray, blue and red, respectively. The ﬁtted Pol I EM-density is
depicted by the blue mesh. The catalytic Mg
2+-ion was added for better orientation (magenta sphere in the middle of the structure). (A) Front view.
(B) Side view without A43/A14. (C) Sequence alignment of the largest subunits of several eukaryotic RNA polymerases, as well as the homologous
subunits from two Archaea species and Escherichia coli. Highlighted amino acids are shown in the structure of the pore/funnel-region below.
A section of the bottom view of a Pol II elongation complex (PDB 1Y77) is presented with the downstream DNA on the right hand side. Rpb1 A759
is not located directly on the surface and thus not shown. (D) Localization of A190 S685 on the backside of the polymerase. A magniﬁcation of the
lower part of the homology model is shown.
798 Nucleic Acids Research, 2008, Vol. 36, No. 3candidate for important interactions with further compo-
nents of the initiation machinery.
In vivophenotypes aftermutation of themajor
Pol I-phosphosites
To study functional consequences of states that mimic
either the non-phosphorylated or constitutively phosphor-
ylated state, each of the single phosphorylated residues
was replaced by either an alanine or aspartate, respec-
tively. The clustered phosphoserines in A190 and A34.5
were each mutated in combination. We replaced each
wild-type subunit by the corresponding mutant copies
and investigated growth complementation at 16, 24, 30
and 378C as well as the resulting growth behavior in the
presence of 6-azauracil (6AU) and rapamycin. 6AU helps
to detect elongation defects by indirectly lowering the
pool of the nucleotides GTP and UTP (37,38), whereas
rapamycin inhibits the TOR pathway through which cells
sense nutrient availability. In total 27 diﬀerent mutants
were generated and analyzed (Supplementary Fig. S3).
None of the mutations showed a signiﬁcant growth
phenotype (data not shown) arguing that crucial steps in
rDNA transcription are not absolutely dependent on the
single phosphosites investigated. Accordingly, for instance
a single phosphorylated residue in subunit A43 or any
other subunits tested cannot be crucial for interaction with
transcription factor Rrn3p, which was previously shown
to be growth-dependent (7). Since we found previously
that in vitro interaction between Rrn3p and Pol I depends
on the phosphorylation status of Pol I (19), it is possible
that either combinations of several phosphosites are
required for Rrn3p-binding or that the crucial site(s) was
yet not identiﬁed. Also, no growth phenotype was detected
if all serines in the motif present both in A190 (S1413/
S1415/S1417) and A34.5 (S10/S12/S14) were exchanged
as well as if both serines S208 and S220 were replaced
in subunit A43. However, a change in growth behavior in
the A190 S685D mutant was observed in the presence of
6AU. Replacement of S685 by an aspartate resisted 6AU
concentrations under which growth of both wild-type
cells and A190 S685A mutants is signiﬁcantly reduced
(Figure 4B). One possible explanation for this phenotype
is that A190 S685D mutants do not respond properly
if environmental conditions produce cellular stress,
which in wild-type cells leads to growth inhibition and
down-regulation of rRNA synthesis. This observation is
supported by the growth behavior of diﬀerent A190 S685-
mutants at elevated temperatures. While the exchange to
an alanine results in almost complete growth inhibition,
wild-type cells can slowly grow at 408C and replacement
of S685 by an aspartate allows even better growth at this
temperature (Figure 4C).
The ﬁnding that many major phosphosites are not
involved in essential functions of Pol I-activity is remini-
scent to the non-essential subunits in Pol I and Pol II
which are not required for growth although their evolu-
tionary conservation suggests that they participate in
important steps of transcription. We investigated system-
atically genetic interactions between most of the mutated
phosphosites and non-essential components of the Pol I
transcription machinery like the Pol I subunits A12.2,
A14, A34.5, A49, the transcription factors Uaf30, Hmo1
and other factors that interact with rDNA chromatin
like the topoisomerases Top1 and Top3 or the histone
assembly factor Asf1 by synthetic lethality assays. We
replaced each phosphorylated Pol I subunit-gene by the
corresponding phospho-mutant allele in the knock out
strain of the candidate interaction partner (Supplementary
Fig. S4). Remarkably, only one of the tested 180 combi-
nations between a mutated phosphoserine/threonine and
a gene deletion revealed a signiﬁcant growth reduction.
This is the same mutation leading to an altered growth
Figure 4. Synthetic lethal eﬀects and growth analysis of A190 S685
mutants. (A) Scheme of Pol I, showing the localization of A190 S685
and A12.2. (B) A yeast strain carrying the mutation A190 S685D is less
sensitive to the NTP-pool depleting drug 6–azauracil (6AU) than the
isogenic wild-type or a strain with the analogous mutation to alanine.
(C) The same mutant (A190 S685D) grows better on YPD at elevated
temperatures (408C) than the corresponding wild-type strain, while the
alanine variant is growth inhibited. (D) Mutation of A190 S685 to
aspartate (left), but not to alanine (middle) is synthetic lethal with a
deletion of RPA12. No genetic interaction with other non-essential
Pol I subunits was observed. The deletion of RPA14 is shown as an
example (right).
Nucleic Acids Research,2008, Vol. 36,No. 3 799behavior on 6AU-plates: replacement of S685 in the sub-
unit A190 by an aspartate, but not by alanine resulted in
synthetic lethality, if RPA12 was lacking, which encodes
the non-essential Pol I subunit A12.2 (Figure 4D).
In contrast yeast strains containing this phosphomutation,
but lacking other non-essential Pol I subunits were not
aﬀected. It is possible that A190 S685 phosphorylation
supports a non-essential function of subunit A12.2, which
was discussed to be involved in elongation and/or
stabilization of Pol I (39), transcription termination (40)
and/or rRNA cleavage (9). If A12.2 is absent, the switch
to phosphorylation might lead Pol I into a dead end
situation, which then also impairs essential functions of
the enzyme and which could only be avoided if S685 stays
dephosphorylated. Accordingly, the viability of a rpa12
strain depends on the non-phosphorylated state of A190
S685. Thus, we conclude that this residue is reversibly
phosphorylated in wild-type cells. Interestingly, A190
S685 is located well apart from A12.2 on the 3D structure
of the enzyme [Figure 3A, B and D, Figure 4A, (9)]
suggesting a functional co-operation of two spatially
separated entities. It is possible that binding of A12.2
induces changes in the structure of Pol I (39) which,
ﬁnally, ensures a high processivity of the enzyme in con-
text with the reversible phosphorylation of A190 S685.
Since subunit A12.2 was reported to be involved in trans-
cription elongation (39), transcription termination (40)
and rRNA cleavage (9) and, furthermore, the A190 S685D
mutation caused growth resistance in the presence of
6AU, it is likely that the phosphorylation of this residue
is involved in rRNA cleavage/elongation or termination.
We are presently investigating which and how these steps
are modulated by A190 S685 phosphorylation.
Phosphorylation and assembly/stability ofPol I
In many cases stability of protein–protein interaction or
degradation of polypeptides depends on a distinct phos-
phorylation pattern (41–44). In particular, subunits
ABC23 and AC19 are the o-like and one of the a-like
subunits of the Pol I complex, respectively, which are
involved in enzyme-assembly (6,10,11,14,15). Therefore,
we analyzed whether dephosphorylation of Pol I results
in a loss of interactions between Pol I subunits. Such
a reduced stability of Pol I could explain the loss of
transcriptional activity which was previously found if
Pol I-containing fractions were treated with alkaline
phosphatase (18,19). Puriﬁed Pol I was dephosphorylated
using alkaline phosphatase and aﬃnity puriﬁed via its His-
tagged A43 subunit under high ionic strength (1.5M KAc)
(Figure 5A). The dephosphorylation reaction resulted in
a shift of subunit A34.5 and A43, respectively to a lower
molecular weight on SDS-gels. No signiﬁcant dissociation
of any subunit could be detected, suggesting that the
phosphosites analyzed are not required for complex stabil-
ity as determined by subsequent western analysis and
silver staining. The loss of transcriptional in vitro activity
after Pol I-dephosphorylation (18,19) can, therefore, not
be due to an instability of the core-enzyme at the promoter
or during the transcription reaction. However, analysis
by phosphostaining demonstrated that it was not possible
to achieve a complete dephosphorylation of subunits A43,
A190 and AC19 (data not shown) even, if extended
incubation times or increased amounts of phosphatase
were used. This suggests that some phosphorylation sites
are not accessible to alkaline phosphatase [see also (29)].
To ﬁnd out whether one of the phosphomutants is aﬀected
in either complex stability or in vivo assembly we system-
atically immunopuriﬁed Pol I from phosphomutant
extracts using high salt conditions (1M NaCl). None of
the mutated Pol I molecules tested diﬀered signiﬁcantly
in their substoichiometric composition suggesting that
phosphorylation of the residues investigated in this
study play neither a role for assembly nor for the stability
of the mutated subunits under the conditions analyzed
(Figure 5B and Supplementary Fig. S2). In particular, this
means that A34.5 phosphorylation is neither required
in formation of the A49/A34.5 dimer (9) nor in the
association of the heterodimer to the core polymerase (8).
S102 of subunit ABC23 is one of the few phosphosites
within interfaces between Pol I subunits. It is located in
close proximity of amino acid Q100 (Figure 2) which is
required for binding of the Pol II-speciﬁc subunits Rpb4
and Rpb7 (45). Exchange of Q100 with an arginine results
in a temperature sensitive phenotype and a reduction in
mRNA- and tRNA- however not in rRNA-synthesis. It is
possible that the modulation of the close-by serine helps
the common ABC23 subunit to distinguish between the
diﬀerent contact sites required for interaction with
the distantly related Pol I, Pol II and Pol III-speciﬁc
Figure 5. Stability of phosphatase-treated and of mutated Pol I
complexes. (A) Puriﬁed Pol I was treated with heat-inactivated (Mock)
or active alkaline phosphatase (AP), aﬃnity puriﬁed and analyzed by
western blotting (upper panel; anti-Pol I antiserum was used) or silver-
staining (lower panel). No signiﬁcant changes in the complex stoichio-
metry were visible. Shifts of dephosphorylated A43 and A34.5 are
indicated by arrows. The asterisk indicates an additional proteinband,
which is due to heat-treated alkaline phosphatase fraction. (B) Pol I
variants and the corresponding wild-types were immunoprecipitated from
whole cell extracts and analyzed by western blotting. Two examples are
shown. No diﬀerences in complex stability were detectable.
800 Nucleic Acids Research, 2008, Vol. 36, No. 3subcomplexes A14/A43, Rpb4/Rpb7 and C17/C25, respec-
tively (13,46–48). However, since S102 mutations exhibit
no signiﬁcant growth phenotype, subunit and enzyme
selection cannot exclusively be triggered by phosphoryla-
tion at this position. It is more likely that S102 phos-
phorylation is involved in a distinct function related to the
largest Pol subunits, since genetic interactions between
ABC23 S102F and an insertion mutation (W954(LELE)P)
positioned in the foot domain of Rpb1 were reported
(10,49). This insertion belongs to the domains which diﬀer
signiﬁcantly between the largest Pol I and Pol II subunits
(9). Further investigations will show whether the phos-
phorylation of ABC23 (2,3,50) appears also in Pol II and
Pol III at the same position and whether this modiﬁcation
is either crucial for the assembly in a speciﬁc polymerase
complex (10,32) or whether it is involved in a regulatory
role as suggested by the 3D-neighborhood of ABC23 to the
clamp (51). Accordingly, similar considerations are possi-
ble for the incorporation of the shared subunit AC19 into
Pol I or Pol III, respectively.
In summary, our systematic studies about the
Pol I-phosphoprotein complex show that, most residues
that are phosphorylated at a molar ratio make no
exclusive contribution to control cellular growth and,
thus, to regulate ribosome synthesis. Furthermore, they
are not essential for subunit stability or enzyme assembly.
In this regard they are reminiscent of yeast Pol I subunits,
which are not essential for growth though they are
evolutionary conserved constituents. Apparently, they
fulﬁll important functions for Pol I which are not
detectable through the growth rate of the respective
deletion strain. Possible roles of these non-essential
subunits are emerging with the application of assays
which allow to resolve single steps of transcription or
processes related to nuclear transcription (8,9,40,52). Our
phosphomutant strains are suitable to perform similar
studies on the function of the major phosphorylated
residues in Pol I subunits. On the other hand, cooperation
between two or more phosphosites might be required to
accomplish a signiﬁcant impact on Pol I assembly or -
activity or, for instance, to allow nuclear import of
(preassembled) Pol I subunits. Investigations of such
combinatorial eﬀects can now be started.
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